Lexaria Bioscience Corp. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Kelowna, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 August
Lexaria Bioscience Corp. has filed 1,088 SEC EDGAR filings since 01 Mar 2006

SEC filing history

Showing 276-300 of 964 matching filings.

Per page
25
Current page
12
4

PRIMARY DOCUMENT

Filing date
09 Jun 2021
Reporting date
07 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2021
Reporting date
08 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2021
Reporting date
07 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39874

DEF 14A

Filing date
14 May 2021
Reporting date
03 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39874

FORM 8-K

Filing date
12 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39874

FORM 8-K

Filing date
16 Apr 2021
Reporting date
15 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
16 Apr 2021
Reporting date
15 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
16 Apr 2021
Reporting date
15 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-238915

EFFECT filing

Filing date
03 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-238915

PROSPECTUS

Filing date
03 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85256

SC 13D/A

Filing date
24 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85256

SC 13G

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
14 Jan 2021
Reporting date
14 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39874

FORM 8-K

Filing date
14 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-250326

424B4

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .